Laura A. Genduso

Olanzapine versus haloperidol in the treatment of schizophrenia and other psychotic disorders: Quality of life and clinical outcomes of a randomized clinical trial

Dennis A. Revicki, Laura A. Genduso, S.H. Hamilton et al. · Quality of Life Research · 1999 · 137 citations

Pharmacy, Pharmacotherapy, Psychiatry +12

Clinical and Economic Outcomes of Olanzapine Compared With Haloperidol for Schizophrenia

S.H. Hamilton, Dennis A. Revicki, E.T. Edgell et al. · PharmacoEconomics · 1999 · 106 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +13

A cost-effectiveness clinical decision analysis model for schizophrenia.

Cynthia S. Palmer, Dennis A. Revicki, Laura A. Genduso et al. · PubMed · 1998 · 76 citations

Pharmacy, Pharmacoeconomics, Psychiatry +17

Continuation treatment of OCD: double-blind and open-label experience with fluoxetine.

Gary D. Tollefson, Martin Birkett, Laura A. Genduso · PubMed · 1994 · 57 citations

Medicine, Pharmacotherapy, Psychiatry +11

Fluoxetine: no association with suicidality in obsessive-compulsive disorder

Charles M. Beasley, Janet H. Potvin, Daniel N. Masica et al. · Journal of Affective Disorders · 1992 · 38 citations

Pharmacy, Pharmacology, Pharmacotherapy +12